35 Years of GLP in Germany: A Brief Overview About Its Successful History

Good Laboratory Practice (GLP) emerged in the 1970s in response to serious deficiencies in the validity and reproducibility of preclinical safety data submitted in the USA. Non-adherence to scientific standards in the use of laboratory methods and the data generated, and even fraudulent practices, led to the establishment of binding regulatory standards, which were later adopted by the OECD as the "Principles of GLP", alongside the Council Decision on the Mutual Acceptance of Data (MAD). This framework, expanded to include compliance monitoring programmes and non-member country participation and has since formed the foundation for international harmonization of non-clinical safety testing. Germany, as an early adopter of the OECD GLP system, provides a prominent example of long-term implementation. Since the national compliance monitoring programme became legally binding in 1990, thousands of inspections were carried out in the meantime. German test facilities cover all OECD-defined areas of expertise and the German compliance monitoring authorities maintain rigorous inspection cycles in line with OECD recommendations, with a notable share operating for decades within the programme. This long-standing infrastructure in Germany contributes to the reliable and robust application of the OECD's GLP principles. This article presents a comprehensive overview of the historical development, international transposition and national application of GLP, using Germany as a case study after 35 years of implementation. By compiling regulatory milestones, structural data, and long-term monitoring outcomes, the publication aims to provide a transparent evidence base for assessing the effectiveness of GLP frameworks. The systematic presentation of these data serves both to document Germany's contribution to the international GLP landscape and to support ongoing discussions on harmonization, resource allocation, and future challenges in non-clinical safety assessment.

Authors

Institutions

Publication Details

Journal
Therapeutic Innovation & Regulatory Science
Published
2026-07-17
DOI
https://doi.org/10.1007/s43441-026-01009-8
Primary Topic
Clinical Laboratory Practices and Quality Control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

35 Years of GLP in Germany: A Brief Overview About Its Successful History

CM Strüh, Sebastian Schmidtsdorff
Therapeutic Innovation & Regulatory Science
Clinical Laboratory Practices and Quality Control
article

35 Years of GLP in Germany: A Brief Overview About Its Successful History

CM Strüh, Sebastian Schmidtsdorff
article en

Abstract

Good Laboratory Practice (GLP) emerged in the 1970s in response to serious deficiencies in the validity and reproducibility of preclinical safety data submitted in the USA. Non-adherence to scientific standards in the use of laboratory methods and the data generated, and even fraudulent practices, led to the establishment of binding regulatory standards, which were later adopted by the OECD as the "Principles of GLP", alongside the Council Decision on the Mutual Acceptance of Data (MAD). This framework, expanded to include compliance monitoring programmes and non-member country participation and has since formed the foundation for international harmonization of non-clinical safety testing. Germany, as an early adopter of the OECD GLP system, provides a prominent example of long-term implementation. Since the national compliance monitoring programme became legally binding in 1990, thousands of inspections were carried out in the meantime. German test facilities cover all OECD-defined areas of expertise and the German compliance monitoring authorities maintain rigorous inspection cycles in line with OECD recommendations, with a notable share operating for decades within the programme. This long-standing infrastructure in Germany contributes to the reliable and robust application of the OECD's GLP principles. This article presents a comprehensive overview of the historical development, international transposition and national application of GLP, using Germany as a case study after 35 years of implementation. By compiling regulatory milestones, structural data, and long-term monitoring outcomes, the publication aims to provide a transparent evidence base for assessing the effectiveness of GLP frameworks. The systematic presentation of these data serves both to document Germany's contribution to the international GLP landscape and to support ongoing discussions on harmonization, resource allocation, and future challenges in non-clinical safety assessment.

Therapeutic Innovation & Regulatory Science
Federal Institute for Risk Assessment (DE)
Partnerships for the goals
Openalex Percentile: Top 9%
Clinical Laboratory Practices and Quality Control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

35 Years of GLP in Germany: A Brief Overview About Its Successful History — CM Strüh, Sebastian Schmidtsdorff · Therapeutic Innovation & Regulatory Science (2026) | TGRS Research Map | TGRS